Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
about
Tuberculosis vaccines: beyond bacille Calmette-GuerinAdvances and hurdles on the way toward a leprosy vaccine.Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosyPreclinical evidence for implementing a prime-boost vaccine strategy for tuberculosisEffect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau[North-South relations in scientific publications: editorial racism?].Selection bias: neighbourhood controls and controls selected from those presenting to a Health Unit in a case control study of efficacy of BCG revaccination.Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsBCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trialIntranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85APaediatric tuberculosis.Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contactsThe clinical utility of tuberculin skin test and interferon-γ release assay in the diagnosis of active tuberculosis among young adults: a prospective observational studySafety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosisBoosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine.Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro.Issues in the design and implementation of vaccine trials in less developed countries.TB incidence in an adolescent cohort in South AfricaImmunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.Vaccine against tuberculosis: what's new?New TB vaccines: is there a requirement for CD8 T cells?Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.Tuberculosis vaccines: current status and future prospects.Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report.Vaccine approaches to prevent tuberculosis.Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis.Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.Current status of new tuberculosis vaccine in children.Recommendations for pediatric tuberculosis vaccination in ItalyTuberculosis: vaccines in the pipeline.Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection.Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
P2860
Q22242669-AF85C695-ADE3-4E6D-BC23-C1CDB7914BF3Q22305432-881189C7-A796-47F5-97E5-44DE2E0D1C2FQ26749927-1DFB970A-4A39-412F-A437-C85221BFC9D0Q28730427-8B8D4D04-588B-4F74-83E7-38D6B50C0153Q28748497-6C8DA1CC-8337-45F4-B271-21DDA07C7761Q30483200-AB02E7D0-B8C3-4616-9F93-78DB9E3CFC6EQ30830069-BED6A1C3-A8B7-4C42-A32E-CC8FB17C3B3EQ33303660-55809166-BC75-4D9A-8A61-D81D0C462EF6Q33319547-25F408D3-0C1C-4167-A0A6-F5685E28BD81Q33466022-1FEC59D2-1F20-428F-B507-D286C9BEC3B2Q33468451-B7CFDB20-591E-4EBA-81DF-D6F1C8B1A074Q33581724-FDC662BC-11BC-4AF2-B329-FB5E5042773AQ33614952-8A4B6A09-AC1D-4C4F-B5CB-7D8B042BB2E0Q33675370-F1AD77A6-4A63-4D68-9F62-7959613F0AF2Q33790058-56A0790F-01D1-4FA3-81AE-872222BCA148Q33875831-E51B9850-D42A-4A76-AC62-94CFAA2BD153Q34055234-C4A3E951-93B6-4E13-BDE7-56955F819CB0Q34190011-CC7B403B-5BAF-4861-A5BD-EF819382A2B9Q34492614-6DE802DF-BFAA-43F4-9062-05A6132E91A1Q34565122-E32F2036-BF4C-4416-81A0-DE24C51EA59FQ34578596-67225869-78CB-4D83-B8AB-8D162F350524Q34637907-6AB8EA7A-3145-4380-8895-D569FFE4D977Q34726923-5BDE1BFB-110D-493C-8646-CB508E698740Q35101472-09048DE1-E3E4-4DDD-B575-A8C6542FBF23Q35916176-C9F7406D-94B5-4FE5-8951-272B704DD9B2Q36145561-6D070A2D-7DF8-4BAB-8CA8-D4E633D1FBEDQ36229621-823D9E95-FF92-4AE7-B531-436A354EDFC6Q36458393-4C473764-631A-40D6-85EC-A17C31842107Q36547958-E6C268B2-845D-4CAE-96B5-E89331EEA4A0Q36570685-B8DFD83B-8217-4B01-8D8B-A4AB3C14FCD5Q36736465-CABEFE43-EE0A-43A3-8D14-9DB3FFFAC7C2Q36899073-E50E814E-5C0C-4033-9195-B5B2C0456A80Q36981662-22F7976D-31C4-426B-9A81-41BD9A3AC3BBQ37033066-A7CDF35F-C4A9-4647-A816-0F2973CBED5DQ37124690-7EC5D608-CD0C-4488-BFE7-F82BC8C4B687Q37130796-C4897384-B086-43F9-A2C4-BBB08B117B36Q37135291-C1312284-143C-48CB-8C3C-699A4864B6FCQ37194790-B9A71E54-CD3A-419B-A16F-BF06636ABA7AQ37309256-60ED3175-625B-41B9-B2AB-3983146B46A5Q37335461-4C0DAB55-A371-4556-ACAF-F758F85A9540
P2860
Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Effect of BCG revaccination on ...... EVAC cluster-randomised trial.
@en
Effect of BCG revaccination on ...... EVAC cluster-randomised trial.
@nl
type
label
Effect of BCG revaccination on ...... EVAC cluster-randomised trial.
@en
Effect of BCG revaccination on ...... EVAC cluster-randomised trial.
@nl
prefLabel
Effect of BCG revaccination on ...... EVAC cluster-randomised trial.
@en
Effect of BCG revaccination on ...... EVAC cluster-randomised trial.
@nl
P2093
P50
P1433
P1476
Effect of BCG revaccination on ...... EVAC cluster-randomised trial.
@en
P2093
Alvaro A Cruz
Bernd Genser
Clemax Sant'Anna
Maria Yury Ichihara
Miguel A Hijjar
Silvana C de Brito
Susan M Pereira
P304
P356
10.1016/S0140-6736(05)67145-0
P407
P577
2005-08-31T00:00:00Z